Chao J, Buse J, Shimamoto K, Margolius H S
Proc Natl Acad Sci U S A. 1981 Oct;78(10):6154-7. doi: 10.1073/pnas.78.10.6154.
Responses of smooth muscle to kallikreins (EC 3.4.21.8) are generally considered to result from kinin formation. This premise was reexamined with the isolated rat uterus. Rat urinary kallikrein or bradykinin produced dose-dependent contractions of rat uterus but kallikrein was 5-fold more potent than bradykinin. Kallikrein caused an immediate series of rhythmic contractions which could be increased gradually with subsequent addition of kininogen substrate. Kallikrein-induced contractions were unaffected by carboxypeptidase B or a bradykinin antiserum whereas bradykinin-induced contractions were attenuated or abolished. Other serine proteinases, including trypsin, either did not induce contraction in the absence of added kininogen or did so minimally. Although small amounts of kininogen-like substrate were found in uterine tissue, detectable kinin levels (greater than 4 pg) could not be found in bathing media during maximal kallikrein-induced contractions or after uterine tissue was incubated with high concentrations of the enzyme in the presence of SQ 20881, a kininase II inhibitor. The data suggest that uterine contraction produced by a homologous kallikrein does not involve kinin formation but results from an action of this serine proteinase upon other accessible systems coupled to the contractile response.
平滑肌对激肽释放酶(EC 3.4.21.8)的反应通常被认为是由激肽形成引起的。本研究使用离体大鼠子宫对这一前提进行了重新检验。大鼠尿激肽释放酶或缓激肽可引起大鼠子宫剂量依赖性收缩,但激肽释放酶的效力比缓激肽高5倍。激肽释放酶可引起一系列即时的节律性收缩,随后添加激肽原底物可使其逐渐增强。激肽释放酶诱导的收缩不受羧肽酶B或缓激肽抗血清的影响,而缓激肽诱导的收缩则减弱或消失。其他丝氨酸蛋白酶,包括胰蛋白酶,在未添加激肽原时不诱导收缩,或诱导作用极小。尽管在子宫组织中发现了少量激肽原样底物,但在激肽释放酶诱导的最大收缩期间或子宫组织在激肽酶II抑制剂SQ 20881存在下与高浓度该酶孵育后,在浴液中未检测到可检测到的激肽水平(大于4 pg)。数据表明,同源激肽释放酶引起的子宫收缩不涉及激肽形成,而是由这种丝氨酸蛋白酶作用于与收缩反应相关的其他可及系统所致。